Viridian Therapeutics, Inc.

Q4 2023 13F Holders

Symbol
VRDN
CUSIP
92790C104
Type
Equity
Class
COM
Num filers
136
Total reported value, excl. options
$1.31B
Manager Report Date Value ($000) Shares Option Type